Toronto - Free Realtime Quote CAD
Helix BioPharma Corp. (HBP.TO)
0.9600
+0.0100
+(1.05%)
As of 10:06:59 AM EDT. Market Open.
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-3,674
-5,219
-5,526
-6,509
-9,304
Investing Cash Flow
15
-14
-5
0
2,020
Financing Cash Flow
5,518
5,506
3,087
6,205
6,562
End Cash Position
1,979
1,081
808
3,252
3,565
Capital Expenditure
-4
-14
-10
--
--
Issuance of Capital Stock
5,518
5,506
4,151
2,994
3,561
Issuance of Debt
--
--
--
0
3,159
Repayment of Debt
-2,468
0
-2,062
0
-158
Free Cash Flow
-3,678
-5,233
-5,536
-6,509
-9,304
7/31/2021 - 8/13/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASEP.CN ASEP Medical Holdings Inc.
0.5000
0.00%
SBM.V Sirona Biochem Corp.
0.0600
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0050
0.00%
FRX.TO Fennec Pharmaceuticals Inc.
9.04
0.00%
NAVB Navidea Biopharmaceuticals, Inc.
0.0006
0.00%
RVX.TO Resverlogix Corp.
0.0450
0.00%
NGEN.V NervGen Pharma Corp.
3.5200
-1.95%
CYBN.NE Cybin Inc.
9.55
+4.49%
NGNE Neurogene Inc.
14.39
-4.10%
TCRT Alaunos Therapeutics, Inc.
2.8400
-5.65%